• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Antibiotic cost control measures in a hospital pharmacy.

作者信息

Manzo J, Amodio-Groton M A, Kleinmann K

机构信息

Department of Pharmacy, Montefiore Medical Center, Henry & Lucy Moses Division, Bronx, New York.

出版信息

Clin Ther. 1993;15 Suppl A:37-43.

PMID:8513460
Abstract

Faced with rising drug costs and an increase in type-1 beta-lactamase resistance, hospitals have been looking for ways to contain antibiotic costs while continuing to provide quality medical care. The hospital pharmacy at Montefiore Medical Center, Moses Division, has developed a number of programs aimed at identifying antibiotic prescribing trends and minimizing costs. An antimicrobial susceptibility cascade reporting (ASCR) system is used to consolidate and target antimicrobial susceptibility information available to the staff physicians. All antibiotics are tested in the microbiology laboratory for susceptibility; however, physicians receive susceptibility reports only for the more cost-effective, conventional antibiotics. Broader-spectrum, more powerful, and usually more expensive antibiotics are not reported with the ASCR system unless resistance to the more cost-effective antibiotics is noted. Two other reforms initiated are expansion of the pharmacy-based intravenous additive program to include antibiotics and the implementation of a drug therapy enhancement program authorizing automatic conversion by the pharmacist of targeted drug regimens to more clinically rational, cost-effective regimens.

摘要

相似文献

1
Antibiotic cost control measures in a hospital pharmacy.
Clin Ther. 1993;15 Suppl A:37-43.
2
Controlling the costs of antibiotic resistance.控制抗生素耐药性的成本。
Clin Ther. 1993;15 Suppl A:3-11.
3
Antibiotic surveillance: the results of a clinical pharmacy intervention program.抗生素监测:一项临床药学干预项目的结果
Hosp Pharm. 1993 Mar;28(3):206-10, 212.
4
Pharmacy-laboratory interactions: a unique method to control antibiotic costs.药房与实验室的互动:一种控制抗生素成本的独特方法。
Hosp Pharm. 1989 Jan;24(1):26-9, 32.
5
Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.抗生素医嘱单指导昂贵药品合理使用对控制成本的影响
Southeast Asian J Trop Med Public Health. 1998 Sep;29(3):636-42.
6
Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.药学部启动的简化经验性抗生素治疗项目。
Hosp Pharm. 1992 Jul;27(7):596-603, 614.
7
Antimicrobial stewardship: bridging the gap between quality care and cost.抗菌药物管理:弥合优质护理与成本之间的差距。
Curr Opin Infect Dis. 2011 Feb;24 Suppl 1:S11-20. doi: 10.1097/01.qco.0000393484.17894.05.
8
The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.微生物学和药学部门在欧洲医院抗生素处方管理中的作用。
J Hosp Infect. 2007 Jun;65 Suppl 2:73-81. doi: 10.1016/S0195-6701(07)60019-X.
9
Antibiotic therapy intervention at a community hospital. Opportunities for cost and quality improvements.社区医院的抗生素治疗干预。成本和质量改进的机会。
Hosp Top. 1995 Spring;73(2):12-5. doi: 10.1080/00185868.1995.9950563.
10
Cost comparison of intravenous antibiotic administration.静脉注射抗生素给药的成本比较
Med J Aust. 1990 Nov 5;153(9):516-8.